Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000039777 | SCV000063466 | benign | not specified | 2011-09-16 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000039777 | SCV000170581 | benign | not specified | 2014-03-07 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000226105 | SCV000291166 | benign | Hypertrophic cardiomyopathy 1 | 2025-01-31 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000226105 | SCV001159052 | benign | Hypertrophic cardiomyopathy 1 | 2023-10-09 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV001170853 | SCV001333474 | benign | Cardiomyopathy | 2019-03-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000039777 | SCV002720541 | likely benign | not specified | 2022-05-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV004716918 | SCV005315017 | benign | not provided | criteria provided, single submitter | not provided |